Your browser doesn't support javascript.
loading
[Antibiotic prophylaxis in urodynamics: Clinical practice guidelines using a formal consensus method]. / Antibioprophylaxie et bilan urodynamique : recommandations de bonne pratique par consensus formalisé.
Egrot, C; Dinh, A; Amarenco, G; Bernard, L; Birgand, G; Bruyère, F; Chartier-Kastler, E; Cosson, M; Deffieux, X; Denys, P; Etienne, M; Fatton, B; Fritel, X; Gamé, X; Lawrence, C; Lenormand, L; Lepelletier, D; Lucet, J-C; Marit Ducamp, E; Pulcini, C; Robain, G; Senneville, E; de Sèze, M; Sotto, A; Zahar, J-R; Caron, F; Hermieu, J-F.
Affiliation
  • Egrot C; Service d'urologie, université Paris-7, hôpital Bichat Claude-Bernard, AP-HP, 46, rue Henri-Huchard, 75018 Paris, France. Electronic address: christophe.egrot@aphp.fr.
  • Dinh A; Unité de maladies infectieuses, UVSQ, hôpital Raymond-Poincaré, AP-HP, 92380 Garches, France.
  • Amarenco G; GRC 01, groupe de recherche clinique en neuro-urologie (GREEN), Sorbonne université, hôpital Tenon, AP-HP, 75020 Paris, France.
  • Bernard L; Service de médecine interne et maladies infectieuses, centre hospitalier régional Bretonneau, 37000 Tours, France.
  • Birgand G; Centre de prévention des infections associées aux soins, CHU de Nantes, 5, rue du Pr-Boquien, 44000 Nantes, France.
  • Bruyère F; Service d'urologie, centre hospitalier régional universitaire de Tours, 37000 Tours, France.
  • Chartier-Kastler E; Médecine Sorbonne Université, hôpital universitaire de la Pitié-Salpêtrière, 75013 Paris, France.
  • Cosson M; Laboratoire BioTIM, école centrale de Lille, université de Lille, CHU de Lille, 59000 Lille, France.
  • Deffieux X; Service de gynécologie obstétrique, université Paris-Sud, hôpital Antoine-Béclère, groupe hospitalier Sud, AP-HP, 92140 Clamart, France.
  • Denys P; Service de neuro-urologie, hôpital Raymond-Poincaré, AP-HP, 92380 Garches, France.
  • Etienne M; Service de maladies infectieuses et tropicales, hôpital Charles-Nicolle, CHU de Rouen, 76000 Rouen, France.
  • Fatton B; Unité d'urogynécologie, groupe hospitalier Carémeau, CHU de Nîmes, 30029 Nîmes, France.
  • Fritel X; Service de gynécologie-obstétrique, CHU de Poitiers, 86000 Poitiers, France.
  • Gamé X; Département d'urologie, transplantation rénale et andrologie, CHU Rangueil, TSA 50032, 31059 Toulouse, France.
  • Lawrence C; Service microbiologie et hygiène, hôpital Raymond-Poincaré, AP-HP, 92380 Garches, France.
  • Lenormand L; Service d'urologie, centre fédératif de pelvipérinéologie, CHU de Nantes, place A.-Ricordeau, 44093 Nantes cedex 01, France.
  • Lepelletier D; Service bactériologie et hygiène hospitalière, CHU de Nantes, 44093 Nantes cedex 01, France.
  • Lucet JC; Service de bactériologie, hygiène, virologie, parasitologie, hôpital Bichat-Claude-Bernard, AP-HP, Paris, France.
  • Marit Ducamp E; Service de médecine physique et réadaptation, urodynamique, clinique Saint-Augustin, 33200 Bordeaux, France.
  • Pulcini C; Infectious Diseases Department, université de Lorraine, APEMAC, CHRU de Nancy, 54000 Nancy, France.
  • Robain G; Service de rééducation neurologique, hôpital Rothschild, AP-HP, 75012 Paris, France.
  • Senneville E; Service universitaire des maladies infectieuses et du voyageur, centre hospitalier Gustave-Dron, CHRU de Lille, 59200 Tourcoing, France.
  • de Sèze M; Service de médecine physique et réadaptation, urodynamique, clinique Saint-Augustin, 33200 Bordeaux, France.
  • Sotto A; Service des maladies infectieuses et tropicales, CHU de Nîmes, place du Professeur-Robert-Debré, 30029 Nîmes cedex, France.
  • Zahar JR; Département de microbiologie, hôpital Avicenne, AP-HP, groupe hospitalier Paris-Seine-Saint-Denis, 93000 Bobigny, France; Unité de recherche Inserm 1137, IAME, université Paris-13, 93000 Bobigny, France.
  • Caron F; Service des maladies infectieuses, groupe de recherche sur l'adaptation microbienne (EA2656), université de Rouen, CHU de Rouen, 76000 Rouen, France.
  • Hermieu JF; Service d'urologie, université Paris-7, hôpital Bichat Claude-Bernard, AP-HP, 46, rue Henri-Huchard, 75018 Paris, France.
Prog Urol ; 28(17): 943-952, 2018 Dec.
Article in Fr | MEDLINE | ID: mdl-30501940
ABSTRACT

OBJECTIVE:

The aim of this work was to issue clinical practice guidelines on antibiotic prophylaxis in urodynamics (urodynamic studies, UDS). MATERIALS AND

METHODS:

Clinical practice guidelines were provided using a formal consensus method. Guidelines proposals were drew up by a multidisciplinary experts group (pilot group = steering group), then rated by a panel of 12 experts (rating group) using a formal consensus method, and then peer reviewed by a reviewing/reading group of experts (different from the rating group).

RESULTS:

Urine (bacterial) culture with antimicrobial susceptibility testing is recommended for all patients before UDS (strong agreement). In patients with no neurologic disease, the risk factors for tract urinary infection (UTI) after UDS are age > 70 years, recurrent UTI, and post-void residual volume > 100ml. In patients with neurologic disease, the risk factors for UTI after UDS are recurrent UTI, vesicoureteral reflux, and intermicturition pressure > 40cmH2O. If the urine culture is negative before UDS and there is no risk factor for UTI, antibiotic prophylaxis is not recommended (Strong agreement). If the urine culture is negative before UDS, but there are one or more risk factors for UTI, antibiotic prophylaxis is optional. If antibiotic prophylaxis is initiated, a single oral dose (3g) of fosfomycin-tromethamine two hours before UDS is recommended (Strong agreement). If there is bacterial colonization on UCB before UDS, antibiotic therapy is optional (Undecided). If prescribed, it should be adapted to the antimicrobial susceptibility of the identified bacterium or bacteria, started the day before and stopped after UDS (except for fosfomycin-tromethamine a single dose the day before UDS is necessary and sufficient) (Strong agreement). In the event of UTI before UDS, the UTI should be treated and UDS postponed (Strong agreement). The proposed recommendations should not be changed for patients with a hip or knee replacement (Strong agreement). No antibiotic prophylaxis of bacterial endocarditis is necessary, including in high-risk patients with valvular heart disease (Strong agreement).

CONCLUSION:

These new guidelines should help to harmonize clinical practice and limit exposure to antibiotics. LEVEL OF EVIDENCE 4.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Tract Infections / Urodynamics / Antibiotic Prophylaxis / Anti-Bacterial Agents Type of study: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans Country/Region as subject: Europa Language: Fr Journal: Prog Urol Journal subject: UROLOGIA Year: 2018 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Tract Infections / Urodynamics / Antibiotic Prophylaxis / Anti-Bacterial Agents Type of study: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans Country/Region as subject: Europa Language: Fr Journal: Prog Urol Journal subject: UROLOGIA Year: 2018 Document type: Article